-The Telegraph New Delhi: Countries negotiating a global declaration on tuberculosis are under pressure to give up their rights to use existing provisions in world trade laws to provide affordable second-line and new anti-TB drugs to their populations, an international humanitarian agency said on Friday. Medecins Sans Frontieres said the US was "exerting extreme pressure" on other negotiators by refusing to sign the declaration if it retained text that "recognises the importance...

-Deccan Chronicle Ayush ministry states that experience and evidence of effectiveness of these drugs is based on textual rationale and published in literature. Hyderabad: Fraudsters would flourish if patented or proprietary Ayruvedic, Siddha and Unani products are given licence without insisting on safety trials, industry experts and medical professionals have stated. The Centre has issued drug regulators in states a directive to issue licenses to patented and proprietary products of Ayurvedic, Siddha and...

-The Telegraph New Delhi: Patients' rights advocates in India on Tuesday filed two oppositions in the Indian patent office, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir and velpatasvir, used to treat hepatitis-C infections. The oppositions filed by the Delhi Network of Positive People (DNP+) challenge Gilead's patent applications for the tablet formulations of the fixed dose combination of sofosbuvir and velpatasvir and a new form...

-PTI NEW DELHI: From running street clinics to giving free-of-cost treatment to poor and homeless, many doctors in old Delhi's Chandni Chowk area are going beyond their line of duty to serve people. A team of three doctors set up a street clinic near the Baptist Church every morning to tend to the poor before going to their work. "I come here for two hours in the morning, tend to those with wounds...

-The Hindu Business Line The Ayushman Bharat programme must aim to reverse poverty caused by healthcare expenses The state of India’s healthcare system is somewhat dichotomous — the country is a global supplier of life-saving, affordable and good quality generic medicines, yet lakhs of families are driven into poverty because they are forced to spend much of their earnings and savings on medications to treat chronic and life-threatening diseases. The poor, particularly,...